Literature DB >> 24578330

American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.

Fernando C Fervenza1, Mark A Perazella, Michael J Choi.   

Abstract

The Nephrology Quiz and Questionnaire (NQ&Q) remains an extremely popular session for attendees of the Annual Meeting of the American Society of Nephrology. As in past years, the conference hall of the 2013 meeting was overflowing with interested audience members. Topics covered by expert discussants included electrolyte and acid-base disorders, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories, along with single best answer questions, were prepared by a panel of experts. Before the meeting, program directors of United States nephrology training programs answered questions through an Internet-based questionnaire. A new addition to the NQ&Q was participation in the questionnaire by nephrology fellows. To review the process, members of the audience test their knowledge and judgment on a series of case-oriented questions prepared and discussed by experts. Their answers are compared in real time using audience response devices with the answers of nephrology fellows and training program directors. The correct and incorrect answers are then briefly discussed after the audience responses and the results of the questionnaire are displayed. This article recapitulates the session and reproduces its educational value for CJASN readers. Enjoy the clinical cases and expert discussions.

Entities:  

Keywords:  focal segmental glomerulosclerosis; glomerulopathy; nephrotic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24578330      PMCID: PMC4011458          DOI: 10.2215/CJN.11571113

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  73 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

Review 2.  Focal and segmental glomerulosclerosis: multiple pathways are involved.

Authors:  Alain Meyrier
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

Review 3.  Minimal change disease: a CD80 podocytopathy?

Authors:  Takuji Ishimoto; Michiko Shimada; Carlos E Araya; Janna Huskey; Eduardo H Garin; Richard J Johnson
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

4.  Rituximab in adult patients with immunosuppressive-dependent minimal change disease.

Authors:  E Hoxha; R A K Stahl; S Harendza
Journal:  Clin Nephrol       Date:  2011-08       Impact factor: 0.975

5.  Effect of single-dose rituximab on primary glomerular diseases.

Authors:  Hidekazu Sugiura; Takashi Takei; Mitsuyo Itabashi; Misao Tsukada; Takahito Moriyama; Chiari Kojima; Toshiharu Shiohira; Ari Shimizu; Yuki Tsuruta; Nobuyuki Amemiya; Tetsuya Ogawa; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta
Journal:  Nephron Clin Pract       Date:  2010-08-06

6.  Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

Authors:  Ashima Gulati; Aditi Sinha; Stanley C Jordan; Pankaj Hari; Amit K Dinda; Sonika Sharma; Rajendra N Srivastava; Asha Moudgil; Arvind Bagga
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

7.  Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome.

Authors:  Noritomo Kurosu; Hidekazu Sugiura; Chihiro Iwasaki; Yukari Asamiya; Chiari Kojima; Takahito Moriyama; Mitsuyo Itabashi; Misao Tsukada; Takashi Takei; Tetsuya Ogawa; Takumi Yoshida; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta
Journal:  Intern Med       Date:  2009-11-02       Impact factor: 1.271

8.  Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.

Authors:  S Fujinaga; Y Ohtomo; D Hirano; N Nishizaki; T Someya; Y Ohtsuka; K Kaneko; T Shimizu
Journal:  Clin Nephrol       Date:  2009-10       Impact factor: 0.975

9.  Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Authors:  Shuichiro Fujinaga; Daishi Hirano; Naoto Nishizaki; Koichi Kamei; Shuichi Ito; Yoshiyuki Ohtomo; Toshiaki Shimizu; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2010-01-05       Impact factor: 3.714

10.  Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.

Authors:  Henriette A C Kyrieleis; Marije M Löwik; Ilse Pronk; Hans R M Cruysberg; Jan A M Kremer; Wim J G Oyen; Bert L P van den Heuvel; Jack F M Wetzels; Elena N Levtchenko
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-24       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.